Published in Medical Letter on the CDC and FDA, February 16th, 1998
"It is the CDC's technical opinion that name-based surveillance ... is the system most likely to provide data necessary for tracking the epidemic," said Kevin M. De Cock, director of the Division of HIV/AIDS Prevention, Surveillance, and Epidemiology at the U.S. Centers for Disease Control and Prevention (CDC). He emphasized the word "technical."
De Cock's comments came in an invited lecture to the 5th Conference on Retroviruses and Opportunistic Infections, held February 1-5,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.